Nanotherapeutics in angiogenesis: synthesis and in vivo assessment of drug efficacy and biocompatibility in zebrafish embryos

Background Carbon nanotubes have shown broad potential in biomedical applications, given their unique mechanical, optical, and chemical properties. In this pilot study, carbon nanotubes have been explored as multimodal drug delivery vectors that facilitate antiangiogenic therapy in zebrafish embryos. Methods Three different agents, ie, an antiangiogenic binding site (cyclic arginine-glycin-easpartic acid), an antiangiogenic drug (thalidomide), and a tracking dye (rhodamine), were conjugated onto single-walled carbon nanotubes (SWCNT). The biodistribution, efficacy, and biocompatibility of these triple functionalized SWCNT were tested in mammalian cells and validated in transparent zebrafish embryos. Results Accumulation of SWCNT-associated nanoconjugates in blastoderm cells facilitated drug delivery applications. Mammalian cell xenograft assays demonstrated that these antiangiogenic SWCNT nanoconjugates specifically inhibited ectopic angiogenesis in the engrafted zebrafish embryos. Conclusion This study highlights the potential of using SWCNT for generating efficient nanotherapeutics.

[1]  W. Cai,et al.  (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  Shuk Han Cheng,et al.  Acute and long-term effects after single loading of functionalized multi-walled carbon nanotubes into zebrafish (Danio rerio). , 2009, Toxicology and applied pharmacology.

[3]  J. Wood,et al.  Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. , 2002, Cancer cell.

[4]  D. Parker,et al.  RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DO3A) conjugate for detecting angiogenesis biomarker alpha(v) beta3 integrin with MRT, mapping. , 2007 .

[5]  Ralph Weissleder,et al.  Magneto/optical annexin V, a multimodal protein. , 2004, Bioconjugate chemistry.

[6]  Shuk Han Cheng,et al.  Cellular and molecular basis of cadmium‐induced deformities in zebrafish embryos , 2000 .

[7]  S. Rajkumar,et al.  A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma. , 2000, Cancer treatment reviews.

[8]  Timothy J. Mitchison,et al.  A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish , 2009, Nature.

[9]  Weibo Cai,et al.  Anti-Angiogenic Cancer Therapy Based on Integrin αvβ3 Antagonism , 2006 .

[10]  M. Prato,et al.  Translocation of bioactive peptides across cell membranes by carbon nanotubes. , 2004, Chemical communications.

[11]  G. Serbedzija,et al.  Zebrafish angiogenesis: A new model for drug screening , 2004, Angiogenesis.

[12]  C. Kimmel,et al.  Stages of embryonic development of the zebrafish , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[13]  J. McFadden,et al.  Triple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy , 2009 .

[14]  H. Dai,et al.  Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Griffioen,et al.  Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. , 2000, Pharmacological reviews.

[16]  Marco Presta,et al.  The zebrafish/tumor xenograft angiogenesis assay , 2007, Nature Protocols.

[17]  W. Cai,et al.  Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism. , 2006, Anti-cancer agents in medicinal chemistry.

[18]  B. Weinstein,et al.  Plumbing the mysteries of vascular development using the zebrafish. , 2002, Seminars in cell & developmental biology.

[19]  W. Cai,et al.  64Cu-Labeled Tetrameric and Octameric RGD Peptides for Small-Animal PET of Tumor αvβ3 Integrin Expression , 2007, Journal of Nuclear Medicine.

[20]  A. Davidoff,et al.  Delivery of Antiangiogenic Agents for Cancer Gene Therapy , 2005, Technology in cancer research & treatment.

[21]  S. Steinberg,et al.  A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  D. Ribatti,et al.  Mammalian tumor xenografts induce neovascularization in zebrafish embryos. , 2007, Cancer research.

[23]  D. Creamer,et al.  Altered vascular endothelium integrin expression in psoriasis. , 1995, The American journal of pathology.

[24]  Conroy Sun,et al.  Functionalized nanoparticles with long-term stability in biological media. , 2009, Small.

[25]  B. Weinstein,et al.  In vivo imaging of embryonic vascular development using transgenic zebrafish. , 2002, Developmental biology.

[26]  M. Prato,et al.  Carbon nanotubes as nanomedicines: from toxicology to pharmacology. , 2006, Advanced drug delivery reviews.

[27]  Wei Wang,et al.  Advances toward bioapplications of carbon nanotubes , 2004 .

[28]  B. Weinstein,et al.  Angiogenic network formation in the developing vertebrate trunk , 2003, Development.

[29]  S. Ekker,et al.  Expression of VE‐cadherin in zebrafish embryos: A new tool to evaluate vascular development , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[30]  Maurizio Prato,et al.  Double functionalization of carbon nanotubes for multimodal drug delivery. , 2006, Chemical communications.

[31]  M. Fishman,et al.  Patterning of angiogenesis in the zebrafish embryo. , 2002, Development.